Publications

5491 Results

The Evolution of Children’s Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Authors
A Lo;A Liu;Y Yasui;S Castellino;K Kelly;A Herrera;JW Friedberg;D Friedman;C Schwartz;K Roberts;L Constine;D Hodgson
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #881
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report

Authors
J Naru;M Othus;C Lin;A Moseley;A List;C Willman;E Pogosova-Agadjanyan;F Wu;F Appelbaum;H Erba;I-M Chen;I Jenkins;J Kennedy;J Delrow;J Whiteaker;J Radich;J Godwin;L Beppu;M Fitzbiggon;M Fang;P Wang;P Gafken;R Ivey;S Meshinchi;T Chauncey;T Lorentzen;U Voytovich;A Paulovich;D Stirewalt
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #522
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Global Proteomic Profiling Identifies Novel Prognostic Biomarkers in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A First-Of-Its-Kind Report Form the Fred Hutch and SWOG

Authors
D Stirewalt;M Othus;Y Naru;J Kennedy;E Pogosova-Agadjanyan;F Appelbaum;L Beppu;T Chauncey;J Delrow;H Erba;P Gafken;J Godwin;M Fitzgibbons;X Hua;I Jenkins;M Fang;R Ivey;C Lin;T Lorentzen;A Moseley;J Radich;J Voytovich;P Wang;J Whiteaker;C Willman;F Wu;S Meshinchi;A Paulovich
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #799
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Allogeneic transplantation in fit older adults is feasible and encouragingly efficacious. Post-remission data from the prospective ECOG-ACRIN (E2906) clinical study

Authors
Y Ofran;Z Sun;J Rowe;D Claxton;M Tallman;D Arber;A Melnick;R Levine;E Paietta;J Godwin;H Lazarus;S Luger;J Foran;M Litzow
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #413
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E2906

Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912

Authors
P Pophali;X Wang;F Zhao;N Kay;C Hanson;M Thomas;S O'Brien;J Barrientos;E Paietta;J Leis;C Zhang;S Coutre;P Barr;A Cashen;A Mato;A Singh;R Little;H Erba;R Stone;M Litzow;M Tallman;T Shanfelt;L Wagner;L Wagner;L Wagner
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #1562
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1912

Duplex Sequencing for Ultra-Low Frequency Measurable Residual Disease Detection in Adult Acute Myeloid Leukemia

Authors
J Higgins;M Othus;L Dillon;T Smith;E Schmidt;J Yaplee;F Lo;C Valentine;J Salk;C Hourigan;J Radich
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3457
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S0106

A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Elderly Patients with Philadelphia-Chromosome (Ph) Positive or Ph-Like Acute Lymphoblastic leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;J Park;M Wieduwilt;D Jeyakumar;G Yaghmour;E Attalah;A Gerds;S O'Brien;J Liesveld;M Othus;M Litzow;R Stone;E Sharon;H Erba
Journal / Conference
American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3397
Year
2021
Research Committee(s)
Leukemia
Study Number(s)
S1318

Risk factors for long-term adjuvant chemotherapy toxicity using pre-treatment host factors and self-rated treatment bother (GP5) in a clinical trial population

Authors
NL Henry;S Kim;R Hays;M Diniz;M Luu;M Tighiouart;R Cecchini;G Yothers;A Rogatko;P Ganz
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), spotlight poster discussion, abst 415; PD5-04
Year
2021
Research Committee(s)
Breast

Patient-Reported Outcomes in ECOG-ACRIN EA1131: A randomized phase III trial of platinum vs. capecitabine in patients with residual triple-negative breast cancer after neoadjuvant chemotherapy

Authors
K Smith;F Zhao;I Mayer;A Tevaarwerk;S Garcia;C Arteaga;WF Symmans;B Park;B Burnette;D Makower;M Block;K Morley;C Jani;C Mescher;S Dewani;U Brown-Glaberman;L Flaum;E Mayer;W Sikov;E Rodler;A DeMichele;J Sparano;A Wolff;K Miller;L Wagner
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), poster, #P4-10-02
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/EA1131

DREAMSeq Trial: Randomized Phase III Trial of Dabrafenib + Trametinib Followed by Ipilimumab + Nivolumab at Progression VS. Ipilimumab + Nivolumab Followed by Dabrafenib + Trametinib in Patients with Advanced BRAFV600 Mutant Melanoma (EA6134)

Authors
M Atkins;S Lee;B Chmielowski;B Harris;A Ribas;A Tarhini;J Kirkwood
Journal / Conference
ASCO Plenary Series, November 16, 2021, oral
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/EA6134